My view is that, like a lot of small businesses trying to grow overseas, COVID has stopped them in their tracks. Result - they will need further funding to get them to the point they hoped to be at 6 months ago. However, there are enough large strategic investors on the register, and maybe outside it, to make it happen. Digital health for Asthma/other respiratory issues is a great place to be long term - this will not be lost on companies and investors in the sector when they look at Adherium.
Ann: Final Director's Interest Notice, page-19
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
